Abstract
In pancreatic cancer, splicing quantitative trait loci analysis identifies a rs1785932 variant that contributes to decreased risk of disease by influencing ELP2 mRNA splicing and blocking the STAT3 oncogenic pathway.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have